Somatrogon

DRUG4 trials

Sponsors

OPKO Health, Inc., Pfizer, Rabin Medical Center

Conditions

Dwarfism, PituitaryGrowth Hormone DeficiencyHealthy Male VolunteersISSSGA

Phase 1

A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations

CompletedNCT03810664

OPKO Health, Inc.Healthy Male Volunteers

Start: 2019-01-18End: 2019-04-19Updated: 2020-04-28

Phase 3

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

CompletedNCT03831880

PfizerGrowth Hormone Deficiency

Start: 2019-02-07End: 2020-08-28Updated: 2021-10-14

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

RecruitingNCT07226089

Rabin Medical CenterISS, SGA

Start: 2026-02-01End: 2028-01-01Target: 254Updated: 2026-04-30

Unknown Phase

A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

RecruitingNCT06587035

PfizerDwarfism, Pituitary

Start: 2025-01-30End: 2028-09-05Target: 50Updated: 2026-08-14

Related Papers

Perception of Treatment Burden With Once Weekly Somatrogon vs Once Daily Genotropin in Pediatric Patients With Growth Hormone Deficiency (GHD): Results From a Randomized Phase 3 Study

Journal of the Endocrine Society2021-05-013 citations